Sign In to Follow Application
View All Documents & Correspondence

Curable Composition And Method

Abstract: A curable resin composition useful for encapsulating solid state devices is describe The composition includes an epoxy resin, a poly(arylene ether) resin, a latent cationic cure catalyst effective to cure the epoxy resin, and about 70 to about 95 weight perce of an inorganic filler, based on the total weight of the curable composition. A method of encapsulating a solid state device with the composition and encapsulated device prepared with the composition are also described.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
12 July 2007
Publication Number
35/2007
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

GENERAL ELECTRIC COMPANY
1 RIVER ROAD, SCHENECTADY, NY

Inventors

1. LU, QIWEI
22, MOUNTAINWOOD DRIVE, SCHENECTADY, NY 12302
2. O'BRIEN, MICHAEL
22, MAPLERIDGE AVENUE, CLIFTON PARK, NY 12065
3. SUSARLA, PARAMEELA
3, SADDLEBROOK DRIVE, CLIFTON PARK, NY 12065
4. VALLANCE, MICHAEL
35, GREYLEDGE DRIVE, LOUDONVILLE, NY 12211

Specification

WO 2007/005346 PCT/US2006/024666
CURABLE COMPOSITION AND METHOD
BACKGROUND OF THE INVENTION
Solid state electronic devices are typically encapsulated in plastic via transfer
molding. Encapsulation protects the device from environmental and mechanical
damage and electrically isolates the device. There are many desired technical features
of encapsulant compositions. Encapsulation of wire-bonded devices requires low
viscosity encapsulant injection, followed by rapid cure and hot ejection. The
encapsulated device must subsequently withstand the rigor of solder assembly onto a
circuit card. The encapsulant must be self-extinguishing in the event of a heat-
producing malfunction of the circuit. And the encapsulant should preferably be
environmentally friendly - flame retardants such as aromatic halides and antimony
oxide should be avoided.
The encapsulation compositions that are currently commercially favored comprise an
epoxy resin, a phenolic hardener, a nucleophilic accelerator to promote stepwise
polymerization, and a mineral filler. These compositions must be refrigerated before
use, leading to increased costs associated with transportation, storage, and waste. The
compositions also suffer from water absorption in the cured state that detracts from
desired physical properties. Furthermore, the compositions often exhibit significant
shrinkage during curing, which creates stresses that decrease the durability of the
cured encapsulation material and can adversely affect the reliability of the
encapsulated electronic device. There is therefore a need for encapsulation
compositions that exhibit improved storage properties, reduced water absorption, and
reduced shrinkage on curing.
BRIEF DESCRIPTION OF THE INVENTION
The above-described and other drawbacks are alleviated by a curable composition
comprising an epoxy resin, a poly(arylene ether) resin, an amount of a latent cationic
cure catalyst effective to cure the epoxy resin; and about 70 to about 95 weight percent
of an inorganic filler, based on the total weight of the curable composition.
1

WO 2007/005346 PCT/US2006/024666
Other embodiments include a method of preparing the curable composition, a method
of encapsulating a solid state device, and a solid state device encapsulated by the
curable composition, as well as its partially cured and fully cured counterparts.
These and other embodiments are described in detail below.
BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 is a side cross-sectional view of an encapsulated solid state device.
DETAILED DESCRIPTION OF THE INVENTION
One embodiment is a curable composition comprising an epoxy resin, a poly(arylene
ether) resin, an amount of a latent cationic cure catalyst effective to cure the epoxy
resin; and about 70 to about 95 weight percent of an inorganic filler, based on the total
weight of the curable composition. In the course of extensive research, the present
inventors have discovered that these curable compositions, when compared to current
epoxy-based encapsulation compositions, exhibit improved storage properties,
reduced shrinkage during curing, and reduced water absorption in the cured state. In
one embodiment, the curable compositions incorporate a flame retardant that provides
excellent flame retardance while avoiding the environmental disadvantages of
halogenated aromatic compounds and antimony oxide and not interfering with the
curing reaction.
While not wishing to be bound by any particular theory of operation, the present
inventors believe that the present compositions cure by cationic, ring-opening, chain-
reaction polymerization. The latent cationic cure catalyst decomposes on heating
during the curing step to produce a strong Bronsted acid, which initiates ring-opening
polymerization. The curing reaction thus forms ether linkages, rather than beta-
hydroxy ether linkages, resulting in reduced hydrophilicity (and therefore reduced
water absorption) in the cured state.
The curable composition comprises an epoxy resin. Suitable classes of epoxy resins
include, for example, aliphatic epoxy resins, cycloaliphatic epoxy resins, bisphenol-A
epoxy resins, bisphenol-F epoxy resins, phenol novolac epoxy resins, cresol-novolac
2

WO 2007/005346 PCT/US2006/024666
epoxy resins, biphenyl epoxy resins, polyfunctional epoxy resins (i.e., epoxy resins
comprising at least three epoxy groups), naphthalene epoxy resins (e.g., EPICLON®
EXA-4700 from Dainippon Ink and Chemicals), divinylbenzene dioxide, 2-
glycidylphenylglycidyl ether, dicyclopentadiene-type (DCPD-type) epoxy resins (e.g.,
EPICLON® HP-7200 from Dainippon Ink and Chemicals), multi aromatic resin type
(MAR-type) epoxy resins, and the like, and combinations thereof. All of these classes
of epoxy resins are known in the art and are both widely commercially available and
preparable by known methods. Specific suitable epoxy resins are described, for
example, in U.S. Patent Nos. 4,882,201 to Crivello et al, 4,920,164 to Sasaki et al.,
5,015,675 to Walles et al., 5,290,883 to Hosokawa et al., 6,333,064 to Gan, 6,518,362
to Clough et al, 6,632,892 to Rubinsztajn et al., 6,800,373 to Gorczyca, 6,878,632 to
Yeager et al.; U.S. Patent Application Publication No. 2004/0166241 to Gallo et al.,
and WO 03/072628 Al to Ikezawa et al. In one embodiment, the epoxy resin has a
softening point of about 25°C to about 150°C. Within this range, the melting point
may be at least about 30°C or at least about 35°C. Also within this range, the melting
point may be up to about 100°C or up to about 50°C. Softening points may be
determined according to ASTM E28-99 (2004). While it is possible to use epoxy
resins with softening points below 25°C, the amounts of such resins should be low
enough so as not to interfere with the desired friability of the curable composition as a
whole.
In one embodiment, the epoxy resin comprises a monomeric epoxy resin (e.g.,
3,3',5,5'-tetramethyl-4,4'-diglycidyloxybiphenyl, available as RSS1407LC from Yuka
Shell), and an oligomeric epoxy resin (e.g., an epoxidized cresol novolac resin, or a
multi aromatic resin such as Nippon Kayaku's NC3000). Monomeric epoxy resins are
typically crystalline solids, whereas oligomeric epoxy resins are typically glasses.
The curable composition may comprise the epoxy resin in an amount of about 70 to
about 98 parts by weight per 100 parts by weight total of the epoxy resin and the
poly(arylene ether) resin. Within this range, the epoxy resin amount may be at least
about 80 parts by weight, or at least about 85 parts by weight. Also within this range,
the epoxy resin amount may be up to about 95 parts by weight, or up to about 90 parts
by weight.
3

WO 2007/005346 PCT/US2006/024666
The curable composition comprises a poly(arylene ether) resin. In one embodiment,
the poly(arylene ether) resin comprises a plurality of repeating units having the
structure

wherein each occurrence of Q2 is independently hydrogen, halogen, primary or
secondary C1-C12 alkyl, C2-C12 alkenyl, C3-C12 alkenylalkyl, C2-C12 alkynyl, C3-C12
alkynylalkyl, C1-C12 hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-C12 hydrocarbyloxy,
C2-C12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen
and oxygen atoms, or the like; and wherein each occurrence of Q1 is independently
halogen, primary or secondary C1-C12 alkyl, C2-C12 alkenyl, C3-C12 alkenylalkyl, C2-
C12 alkynyl, C3-C12 alkynylalkyl, C1-C12 hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-
C12 hydrocarbyloxy, or C2-C12 halohydrocarbyloxy wherein at least two carbon atoms
separate the halogen and oxygen atoms, or the like.
In one embodiment, the poly(arylene ether) resin may have an intrinsic viscosity of
about 0.03 to 1 deciliters per gram measured at 25°C in chloroform. Within this
range, the intrinsic viscosity may be at least about 0.1 deciliters per gram, of at least
about 0.2 deciliters per gram. Also within this range, the intrinsic viscosity may be up
to about 0.6 deciliters per gram, or up to about 0.4 deciliters per gram. Methods of
preparing poly(arylene ether) resins are known in the art and include, for example,
U.S. Patent Nos. 3,306,874 and 3,306,875 to Hay.
In another embodiment, the poly(arylene ether) resin may have an intrinsic viscosity
of about 0.03 to 0.15 deciliters per gram measured at 25°C in chloroform. Within this
range, the intrinsic viscosity may be at least about 0.05 deciliters per gram, or at least
about 0.07 deciliters per gram. Also within this range, the intrinsic viscosity may be
4

WO 2007/005346 PCT/US2006/024666
up to about 0.12 deciliters per gram, or up to about 0.10 deciliters per gram. Methods
of preparing low intrinsic viscosity poly(arylene ether) resins include, for example,
those described in U.S. Patent No. 6,307,010 Bl to Braat et al, and U.S. Patent
Application Publication No. 2005/0070685 Al to Mitsui et al.
In one embodiment, the poly(arylene ether) resin has the structure

wherein each occurrence of Q2 is independently hydrogen, halogen, primary or
secondary C1-C12 alkyl, C2-C12 alkenyl, C3-C12 alkenylalkyl, C2-C12 alkynyl, C3-C12
alkynylalkyl, C1-C12 hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-C12 hydrocarbyloxy,
C2-C12 halohydrocarbyloxy wherein at least two carbon atoms separate the halogen
and oxygen atoms, or the like; and wherein each occurrence of Q1 is independently
hydrogen, halogen, primary or secondary C1-C12 alkyl, C2-C12 alkenyl, C3-C12
alkenylalkyl, C2-C12 alkynyl, C3-C12 alkynylalkyl, C1-C12 hydroxyalkyl, phenyl, C1-
C12 haloalkyl, C1-C12 hydrocarbyloxy, C2-C12 halohydrocarbyloxy wherein at least
two carbon atoms separate the halogen and oxygen atoms, or the like; each occurrence
of x is independently 1 to about 100; z is 0 or 1; and Y has a structure selected from

wherein each occurrence of R1 and R2 is independently selected from hydrogen and
C1-C12 hydrocarbyl. (As used herein, the term "hydrocarbyl", whether used by itself,
or as a prefix, suffix, or fragment of another term, refers to a residue that contains only
carbon and hydrogen. The residue may be aliphatic or aromatic, straight-chain, cyclic,
5

WO 2007/005346 PCT/US2006/024666
bicyclic, branched, saturated, or unsaturated. It may also contain combinations of
aliphatic, aromatic, straight chain, cyclic, bicyclic, branched, saturated, and
unsaturated hydrocarbon moieties.) Methods for producing these poly(arylene ether)
resins, sometimes called "dihydroxy" or "difunctional" or "bifunctional" poly(arylene
ether) resins are described, for example, in U.S. Patent Nos. 3,496,236 to Cooper et
al., 4,140,675 and 4,165,422 and 4,234,706 to White, 4,521,584 and 4,677,185 to
Heitz et al., 4,562,243 and 4,663,402 and 4,665,137 to Percec, 5,021,543 to Mayska et
al., 5,880,221 to Liska et al., 5,965,663 to Hayase, 6,307,010 Bl to Braat et al.,
6,569,982 to Hwang et al., and 6,794,481 to Amagai et al.
In one embodiment, the poly(arylene ether) resin comprises at least one terminal
functional group selected from carboxylic acid, glycidyl ether, vinyl ether, and
anhydride. A method for preparing a poly(arylene ether) resin substituted with
terminal carboxylic acid groups is provided in the working examples, below. Other
suitable methods include those described in, for example, European Patent No.
261,574 Bl to Peters et al. Glycidyl ether-functionalized poly(arylene ether) resins
and methods for their preparation are described, for example, in U.S. Patent Nos.
6,794,481 to Amagai et al. and 6,835,785 to Ishii et al., and U.S. Patent Application
Publication No. 2004/0265595 Al to Tokiwa. Vinyl ether-functionalized
poly(arylene ether) resins and methods for there preparation are described, for
example, in U.S. Statutory Invention Registration No. H521 to Fan. Anhydride-
functionalized poly(arylene ether) resins and methods for their preparation are
described, for example, in European Patent No. 261,574 Bl to Peters et al., and U.S.
Patent Application Publication No. 2004/0258852 Al to Ohno et al.
In one embodiment, the poly(arylene ether) resin is substantially free of particles
having an equivalent spherical diameter greater than 100 micrometers. The
poly(arylene ether) resin may also be free of particles having an equivalent spherical
diameter greater than 80 micrometers, or greater than 60 micrometers. Methods of
preparing such a poly(arylene ether) are known in the art and include, for example,
sieving.
6

WO 2007/005346 PCT/US2006/024666
The curable composition may comprise about 2 to about 30 parts by weight of the
poly(arylene ether) resin per 100 parts by weight total of the epoxy resin and the
poly(arylene ether) resin. Within this range, the poly(arylene ether) amount may be at
least about 5 parts by weight, or at least about 10 parts by weight. Also within this
range, the poly(arylene ether) may be up to about 20 parts by weight, or up to about 15
parts by weight.
The curable composition comprises an amount of a latent cationic cure catalyst
effective to cure the epoxy resin. A latent cationic cure catalyst is a compound
capable of thermally generating a cationic cure catalyst, which in turn is capable of
catalyzing epoxy homopolymerization. Suitable latent cationic cure catalysts include,
for example, diaryliodonium salts, phosphonic acid esters, sulfonic acid esters, certain
carboxylic acid esters, phosphonic ylides, benzylsulfonium salts, benzylpyridinium
salts, benzylammonium slats, isoxazolium salts such as Woodward's reagent and
Woodward's reagent K, and combinations thereof.
In one embodiment, the latent cationic cure catalyst comprises a diaryliodonium salt
having the structure
[(R3)(R4)I]+X-
wherein R3 and R4 are each independently a C6-C14 monovalent aromatic hydrocarbon
radical, optionally substituted with from 1 to 4 monovalent radicals selected from C1-
C20 alkyl, C1-C20 alkoxy, nitro, chloro, and like radicals which are substantially inert
under encapsulation conditions; and wherein X" is an anion, preferably a weakly basic
anion. Suitable diaryliodonium salts are described, for example, in U.S. Patent Nos.
4,623,558 to Lin, 4,882,201 to Crivello et al., and 5,064,882 to Walles et al. In one
embodiment, the anion X- is an MQd- anion, wherein M is a metal or metalloid, each
occurrence of Q is independently halogen or perhalogenated phenyl, and d is an
integer of 4 to 6. Suitable metals or metalloids, M, include metals such as Fe, Sn, Bi,
Al, Ga, In, Ti, Zr, Sc, V, Cr, Mn, Cs; rare earth elements such as the lanthanides, for
example, Cd, Pr, Nd, and the like, actinides, such as Th, Pa, U, Np, and the like; and
metalloids such as B, P, As, Sb, and the like. In one embodiment, M is B, P, As, Sb
7

WO 2007/005346 PCT/US2006/024666
or Ga. Representative MQd- anions include, for example, BF4-, B(C6CL5)4-, PF6-, ASF6-
, SbF6-, FeCl4-, SnCl6-, SbCl6-, BiCl5-, and the like.
In another embodiment, the latent cationic cure catalyst comprises a diaryliodonium
salt having the structure
[(R3)(R4)I]+ SbF6-
wherein R3 and R4 are each independently a C6-C14 monovalent aromatic hydrocarbon
radical, optionally substituted with from 1 to 4 monovalent radicals selected from C1-
C20 alkyl, C1-C20 alkoxy, nitro, and chloro, and like radicals which are substantially
inert under encapsulation conditions. An exemplary latent cationic cure catalyst is 4-
octyloxyphenyl phenyl iodonium hexafluoroantimonate.
The curable composition comprises the latent cationic cure catalyst in an amount
effective to cure the epoxy resin. The precise amount will depend on the type and
amount of epoxy resin, the type of latent cationic cure catalyst, and the presence of
other composition components that may accelerate or inhibit curing. Generally, the
latent cationic cure catalyst will be present in an amount of about 0.1 to about 10 parts
by weight per 100 parts by weight of the epoxy resin. Within this range, the amount
may be at least about 0.2 parts by weight, or at least about 0.5 parts by weight. Also
within this range, the amount may be up to about 5 parts by weight, or up to about 2
parts by weight.
The curable composition comprises about 70 to about 95 weight percent of an
inorganic filler, based on the total weight of the curable composition. In one
embodiment, the inorganic filler is selected from metal oxides, metal nitrides, metal
carbonates, metal hydroxides, and combinations thereof. In one embodiment, the
inorganic filler may be alumina, silica (including fused silica and crystalline silica),
boron nitride (including spherical boron nitride), aluminum nitride, silicon nitride,
magnesia, magnesium silicate, and the like, and combinations thereof. In one
embodiment, the inorganic filler comprises a fused silica. In one embodiment, the
inorganic filler comprises, based on the total weight of inorganic filler, about 75 to
about 98 weight percent of a first fused silica having an average particle size of 1
8

WO 2007/005346 PCT/US2006/024666
micrometer to about 30 micrometers, and about 2 to about 25 weight percent of a
second fused silica having an average particle size of about 0.03 micrometer to less
than 1 micrometer. Within the above range, the amount of the first fused silica filler
may be at least 80 weight percent, or at least 85 weight percent. Also within the
above range, the amount of the first fused silica filler may be up to 95 weight percent,
or up to 92 weight percent. Within the above range, the amount of the second fused
silica filler may be at least about 5 weight percent, or at least about 8 weight percent.
Also within the above range, the amount of the second fused silica filler may be up to
about 20 weight percent, or up to about 15 weight percent.
The curable composition may, optionally, further comprise an effective amount of a
curing co-catalyst. Suitable curing co-catalysts include, for example, free-radical
generating aromatic compounds (e.g., benzopinacole), copper (II) salts of aliphatic
carboxylic acids (e.g., copper (II) stearate), copper (II) salts of aromatic carboxylic
acids (e.g., copper (II) benzoate, copper (II) naphthenate, and copper (II) salicylate),
copper (II) acetylacetonate, peroxy compounds (e.g., t-butyl peroxybenzoate, 2,5-bis-t-
butylperoxy-2,5-dimethyl-3-hexyne, and other peroxy compounds as described, for
example, in U.S. Patent No. 6,627,704 to Yeager et al.), and the like, and
combinations thereof. In one embodiment, the curing co-catalyst comprises
benzopinacole. In another embodiment, the curing co-catalyst comprises copper (II)
acetylacetonate. A suitable amount of curing co-catalyst will depend on the type of
co-catalyst, the type and amount of epoxy resin, and the type and amount of latent
cationic cure catalyst, among other factors, but it is generally about 0.01 to about 20
parts by weight per 100 parts by weight of epoxy resin.
The curable composition may, optionally, further comprise a rubbery modifier
selected from polybutadienes, hydrogenated polybutadienes, polyisoprenes,
hydrogenated polyisoprenes, butadiene-styrene copolymers, hydrogenated butadiene-
styrene copolymers, butadiene-acrylonitrile copolymers, hydrogenated butadiene-
acrylonitrile copolymers, polydimethylsiloxanes, poly (dimethysiloxane-co-
diphenylsiloxane)s, and combinations thereof; wherein the rubbery modifier
comprises at least one functional group selected from hydroxy, hydrocarbyloxy, vinyl
ether, carboxylic acid, anhydride, and glycidyl. Suitable rubbery modifiers include,
9

WO 2007/005346 PCT/US2006/024666
for example, hydroxy-terminated polybutadienes, carboxy-tenninated polybutadienes,
maleic anhydride-functionalized ("maleinized") polybutadienes, epoxy-terminated
polybutadienes, hydroxy-terminated hydrogenated polybutadienes, carboxy-terminated
hydrogenated polybutadienes, maleic anhydride-functionalized hydrogenated
polybutadienes, epoxy-terminated hydrogenated polybutadienes, hydroxy-terminated
styrene-butadiene copolymers (including, random, block, and graft copolymers),
carboxy-terminated styrene-butadiene copolymers (including, random, block, and
graft copolymers), maleic anhydride functionalized styrene-butadiene copolymers
(including, random, block, and graft copolymers), epoxy-terminated styrene-butadiene
copolymers (including, random, block, and graft copolymers), butadiene-acrylonitrile
copolymers, hydrogenated butadiene-acrylonitrile copolymers, hydroxy-terminated
(i.e., silanol-terminated) polydimethylsiloxanes, hydrocarbyloxy-terminated (i.e.,
carbinol-terminated) polydimethylsiloxanes, carboxy-terminated
polydimethylsiloxanes, anhydride-terminated polydimethylsiloxanes, epoxy-
terminated polydimethylsiloxanes, hydroxy-terminated poly(dimethysiloxane-co-
diphenylsiloxane)s, carboxy-terminated poly(dimethysiloxane-co-diphenylsiloxane)s,
anhydride-terminated poly(dimethysiloxane-co-diphenylsiloxane)s, epoxy-terminated
poly(dimethysiloxane-co-diphenylsiloxane)s, the like, and combinations thereof.
These rubbery modifiers and methods for their preparation are known in the art, and
most are commercially available. A suitable amount of rubbery modifier will depend
on the type of flame retardant, the type and amount of epoxy resin, the type and
amount of polyphenylene ether, and the filler loading, among other factors, but it is
generally about 1 to about 30 parts by weight per 100 parts by weight of the epoxy
resin. Rubbery modifiers may be in the form of finely dispersed particles or reactive
liquids.
The curable composition may, optionally, further comprise one or more additives
known in the art. Such additives include, for example, phenolic hardeners, anhydride
hardeners, silane coupling agents, flame retardants, mold release agents, pigments,
thermal stabilizers, adhesion promoters, and the like, and combinations thereof.
Those skilled in the art can select suitable additives and amounts. When phenolic
hardeners and/or anhydride hardeners are present, they are used in an amount such that
10

WO 2007/005346 PCT/US2006/024666
the primary curing mechanism is epoxy homopolymerization induced by the cure
catalyst.
In one embodiment, the composition is substantially free of polystyrene polymers,
including high impact polystyrenes. Such polystyrene polymers may be defined, for
example, by reference to U.S. Patent No. 6,518,362 to Clough et al.
One embodiment is a curable composition, comprising: about 70 to about 98 parts by
weight of an epoxy resin comprising a monomeric epoxy resin and an oligomeric
epoxy resin; about 2 to about 30 parts by weight of a poly(2,6-dimethyl-l,4-phenylene
ether) resin having an intrinsic viscosity of about 0.05 to about 0.10 deciliters per
gram at 25°C in chloroform; an amount of a diaryliodonium salt effective to cure the
epoxy resin; wherein the diaryliodonium salt has the structure
[(R10)(R11)I]+SbF6-
wherein R10 and R11 are each independently a C6-C14 monovalent aromatic
hydrocarbon radical, optionally substituted with from 1 to 4 monovalent radicals
selected from C1-C20 alkyl, C1-C20 alkoxy, nitro, and chloro; and about 70 to about 95
weight percent silica filler, wherein the silica filler comprises about 75 to about 98
weight percent of a first fused silica having an average particle size of 1 micrometer to
about 30 micrometers, and about 2 to about 25 weight percent of a second fused silica
having an average particle size of about 0.03 micrometer to less than 1 micrometer;
wherein the parts by weight of the epoxy resin and the poly(arylene ether) are based
on 100 parts by weight total of the epoxy resin and the poly(arylene ether); and
wherein the weight percent of the silica filler is based on the total weight of the
curable composition.
As the composition is defined as comprising multiple components, it will be
understood that each component is chemically distinct, particularly in the instance that
a single chemical compound may satisfy the definition of more than one component.
The invention includes methods of preparing the curable composition. One such
embodiment is a method of preparing a curable composition, the method comprising
11

WO 2007/005346 PCT/US2006/024666
blending an epoxy resin, a poly(arylene ether) resin, an amount of a latent cationic
cure catalyst effective to cure the epoxy resin, and about 70 to about 95 weight percent
of an inorganic filler, based on the total weight of the curable composition, to form an
intimate blend. Another embodiment is a method of preparing a curable composition,
comprising: dry blending an epoxy resin, a poly(arylene ether) resin, an amount of a
latent cationic cure catalyst effective to cure the epoxy resin, and about 70 to about 95
weight percent of an inorganic filler, based on the total weight of the curable
composition, to form a first blend; melt mixing the first intimate blend at a
temperature of about 90 to about 115°C to form a second blend; cooling the second
blend; and grinding the cooled second blend to form the curable composition.
The invention includes methods of encapsulating a solid state device with the curable
composition. Thus, one embodiment is a method of encapsulating a solid state
device, comprising: encapsulating a solid state device with a curable composition
comprising an epoxy resin, a poly(arylene ether) resin, an amount of a latent cationic
cure catalyst effective to cure the epoxy resin, and about 70 to about 95 weight percent
of an inorganic filler, based on the total weight of the curable composition; and curing
the composition. Curing the composition may, optionally, include post-curing the
encapsulated devices (e.g., at about 150 to about 190°C for about 0.5 to about 8 hours
in a convection oven). Suitable methods for encapsulating solid state devices are
known in the art and described, for example, in U.S. Patent Nos. 5,064,882 to Walles,
6,632,892 B2 to Rubinsztajn et al, 6,800,373 B2 to Gorczyca, 6,878,783 to Yeager et
al.; U.S. Patent Application Publication No. 2004/0166241 Al to Gallo et al.; and
International Patent Application No. WO 03/072628 Al to Ikezawa et al.
The invention includes encapsulated devices prepared from the curable composition.
Thus, one embodiment is an encapsulated solid state device, comprising: a solid state
device; and a curable composition encapsulating the solid state device, wherein the
curable composition comprises an epoxy resin, a poly(arylene ether) resin, an amount
of a latent cationic cure catalyst effective to cure the epoxy resin, and about 70 to
about 95 weight percent of an inorganic filler, based on the total weight of the curable
composition. Such encapsulated solid state devices include those in which the resin
composition is uncured, partially cured, and fully cured.
12

WO 2007/005346 PCT/US2006/024666
FIG. 1 is a side cross-sectional view of an encapsulated solid state device, 10. The
solid state device 20 is attached to copper leadframe 30 via adhesive layer 40. The
solid state device 10 is electrically connected to the copper leadframe 30 via gold
wires 50 and ground bonds 60. Cured molding compound 70 encapsulates the solid
state device 20, any exposed edges of the adhesive layer 40, gold wires 50, ground
bonds 60, and a portion of the copper lead frame 30, leaving exposed the pad 80,
corresponding to a surface of the copper leadframe 30 beneath the solid state device
20.
The invention is further illustrated by the following non-limiting examples.
EXAMPLES 1-5
Table 1 presents the amounts of materials, expressed in parts by weight, combined to
make Example Formulations 1-5. Example 1 had no polyphenylene ether. The other
examples had poly(2,6-dimethyl-l,4-phenylene ether)s of different molecular weight
(as measured by intrinsic viscosity (IV)). Examples 2-5 contained poly(2,6-dimethyl-
1,4-phenylene ether)s of intrinsic viscosities 0.12, 0.20, 0.25, and 0.30, respectively.
The polyphenylene ethers were passed through a 400 mesh sieve (opening size 37
micrometers) before formulation. "Denka FB570 silica" is a fused silica obtained
from Denka having a median particle size of 17.7 micrometers and a surface area of
3.1 meter 2/gram. "Denka SFP silica" is a fused silica obtained from Denka having a
median particle size of 0.7 micrometers and a surface area of 6.2 meter /gram.
"Epoxy Silane", obtained from GE Advanced Materials, is 2-(3,4-epoxycyclohexyl)-
ethyl-trimethoxysilane. "Yuka RSS1407LC epoxy", obtained from Yuka Shell, is
3,3',5,5'-tetramethyl-4,4'-diglycidyloxybiphenyl. OPPI is 4-octyloxyphenyl phenyl
iodonium hexafluoroantimonate available from GE Advanced Materials-Silicones as
UV9392c.
Curable compositions were prepared by mixing the ingredients first in a Henschel
mixer, and then passing them through a twin-screw extruder set at 60°C in the rear
section and 90°C in the front. After cooling and hardening, the materials were then
ground to a powder using a Retch mill.
13

WO 2007/005346 PCT/US2006/024666
Spiral flow lengths, expressed in centimeters (cm), were determined according to
ASTM standard D3123-98 (also SEMI G11-88), using the standard spiral flow mold
specified therein. A 20-gram charge of the molding compound was transferred into
the spiral cavity of the tool, and the length traveled by the compound before flow
stopped due to cure / pressure drop, was measured. The injection speed and injection
pressure were kept constant across all formulations at 5.84 centimeters/second and 6.9
megapascals (MPa), respectively. Mold temperature was maintained at 175°C.
Specimens for flexural strength, thermomechanical analysis (TMA), and moisture
absorption measurements were prepared by transfer molding as follows. A 15-ton
resin transfer press (Fujiwa) was used. A four-cavity "Izod" specimen mold was used
to transfer-mold a 35-gram charge of curable composition under an injection pressure
of 6.9 MPa, at a ram speed of 2.54 millimeters/sec. The mold was maintained at
175°C, and a two-minute cure cycle was used. Specimens were post-cured in a forced-
air convection oven for six hours at 175°C.
Thermomechanical analysis was used to determine the coefficient of thermal
expansion (CTE) and the glass transition (Tg) of the molded EMC. Thermomechanical
analysis was performed on a Perkin Elmer TMA 7 Instrument. Transfer-molded
specimens measuring at least 3 millimeters (mm) in each dimension were used. The
sample temperature was first ramped at 5°C/min from 25°C to 250°C then cooled at
5°C/min to 0°C. The second heat, used for analysis, ramped from 0°C at 5°C/min to
250°C. An initial vertical probe force of 0.05 Newton was used. Glass transition
temperature, Tg, was taken as the point of intersection of two tangents drawn to the
dimension-temperature curve, at 50°C and 190°C. The measurements are made under
a Nitrogen atmosphere at 100 milliliters/minute. CTE values are expressed in units of
parts per million per degree centigrade (ppm/°C); CTE1 is the CTE value below Tg,
and CTE2 is the CTE value above TK.
Moisture absorption was measured according to SEMI G66-96 standard test method
(saturated area), with the exception of the sample dimensions and drying schedule.
Four transfer-molded specimens (6.35 x 1.25 x 0.3 cm in size, standard "Izod"
dimensions) were used. The dry weight of each specimen was noted after oven drying
14

WO 2007/005346 PCT/US2006/024666
for 1 hour at 110°C. The samples were then conditioned in a humidity controlled
chamber at 85°C and 85% RH for 168 hours. Moist weights were measured within
about 10 minutes of removing the samples from the conditioning chamber, holding
the specimens in a closed, humid container in the interim.
Adhesion to copper substrate was measured according to SEMI G69-0996, "Test
Method for measurement of adhesive strength between leadframes and molding
compounds". The "pull" method was used, with a 5-mil thick copper substrate
transfer-molded into a block of molding compound, 2.8 mm thick. (The leadframe and
tool recommended by the SEMI standard were not used - however, the test specimen
geometry is similar to the recommended standard.) The copper substrate used was
EFTEC 64T ½ H grade from Furukawa Metals. The adhesive area (the triangular
portion of the copper that was molded into the molding compound) was about 15.2
mm , including both sides. The adhesion of the mold compound to copper was tested
by pulling the copper "tab" out of the mold compound using an Instron tensile tester,
at the rate of 2 mm/min. The peak load was recorded and reported as the adhesive
strength. The peak load was measured in pounds and converted to Newtons (N) for
reporting.
To determine flexural strength, the samples (6.35 cm x 1.27 cm x 0.3175 cm) were
tested at room temperature according to ASTM D790 for three-point bend flexural
test.
15

WO 2007/005346 PCT/US2006/024666
Table 1

Ingredient Example 1 Examples 2-5
Denka FB570 Silica 760.32 756.54
Denka SFP Silica 84.48 84.08
Epoxy Silane 4.97 4.97
Yuka RSS1407LC Epoxy 139.49 123.09
OPPI 2.98 5.58
Benzopinacole 1.79 3.35
Polyphenylene ether 0 16.40
Carnauba Wax 3.98 3.98
Carbon Black 1.99 2.00
Property results for Examples 1-5 are summarized in Table 2. The results show a
reduction in moisture absorption for all poly(arylene ether)-containing samples (Exs.
2-5) and an increase in copper adhesion for two of four poly(arylene ether)-containing
samples (Exs. 2 and 3), all relative to Ex. 1 without poly(arylene ether).
16

WO 2007/005346 PCT/US2006/024666
Table 2

Test Ex. 1 Ex.2 Ex.3 Ex.4 Ex.5
Spiral Flow (cm) 89.9 73.2 73.4 61.7 73.2
CTE1 (ppm/°C) 13 11 12 12 12
CTE2 (ppm/°C) 43 38 36 36 35
Tg(°C) 127 120 118 126 119
Moisture Abs. (%) 0.285 0.264 0.268 0.266 0.267
Adhesion (N) 110 113 130 110 102
Flex. Strength (MPa) 118 100 99 107 95
EXAMPLES 6-8
The formulations in Table 3 were mixed, molded, and tested as described for
Examples 1-5. "Sumitomo ECN-195XL-25", obtained from Sumitomo Chemical, is
an epoxidized ortho-cresol novolac resin. Example 6 did not contain polyphenylene
ether. Examples 7 and 8 contained poly(2,6-dimethyl-l,4-phenylene ether) resins with
intrinsic viscosities of 0.12 and 0.30, respectively.
17

WO 2007/005346 PCT/US2006/024666
Table 3.

Ingredient Example 6 Examples 7 & 8
Denka FB570 Silica 1494.00 1494.00
Denka SFP Silica 166.00 166.00
Epoxy Silane 9.74 9.74
Yuka RSS1407LC Epoxy 214.82 182.59
Sumitomo ECN-195XL-25 92.06 78.25
OPPI 7.67 7.67
Benzopinacole 4.60 4.60
Polyphenylene ether 0 46.03
Carnauba Wax 8.00 8.00
Carbon Black 4.00 4.00
Table 4 shows the results obtained for Examples 6-8. The results show that the
poly(arylene ether)-containing Examples 7 and 8 exhibit reduced moisture absorption
and increased copper adhesion relative to Example 6 without poly(arylene ether).
18

WO 2007/005346 PCT/US2006/024666
Table 4.

Test Ex.6 Ex.7 Ex.8
Spiral Flow (cm) 105.4 93.5 63
CTE1 (ppm/°C) 14 13 13
CTE2 (ppm/°C) 42 34 36
Tg(°C) 137 132 136
Moisture Abs. (%) 0.332 0.296 0.306
Adhesion (N) 69 111 92
Flex. Strength (MPa) 123.5 101.5 117.1
EXAMPLES 9 AND 10
The formulations in Table 5 were prepared and tested as described for Examples 1-5.
Both Examples 9 and 10 included a poly(2,6-dimethyl-l,4-phenylene ether) having an
intrinsic viscosity of 0.12 deciliters/gram at 25°C.
19

WO 2007/005346 PCT/US2006/024666
Table 5.

Ingredient Ex.9 Ex. 10
Denka FB570 Silica 1521.00 1521.00
Denka SFP Silica 169.00 169.00
Epoxy Silane 10.00 10.00
RSS1407LC Epoxy Resin 55.38 47.08
(Yuka Shell)
ECN-195XL-25 221.54 188.31
(Sumitomo)
OPPI 3.32 3.32
Benzopinacole 1.66 1.66
Polyphenylene ether 0 41.54
Carnauba Wax 8.00 8.00
Carbon Black 4.00 4.00
Property results for Examples 9 and 10 are presented in Table 6. The results show
that Example 10, containing poly(arylene ether), exhibited reduced moisture
absorption and increased copper adhesion relative to Example 9 without poly(arylene
ether).
20

WO 2007/005346 PCT/US2006/024666
Table 6.

Test Ex.9 Ex.10
Spiral Flow (cm) at 175°C 72.9 69.6
Spiral Flow (cm) at 165°C 94.7 85.3
CTE1 (ppm/°C) 11 13
CTE2 (ppm/°C) 41 35
Tg (°C) 142 141
Moisture Abs. (%) 0.323 0.298
Adhesion (N) 56 76
Flex. Strength (MPa) 137.7 114.7
EXAMPLES 11-14
Four compositions varying in the type and amount of added poly(arylene ether) were
prepared. Example 11 contained no poly(arylene ether), Example 12 contained
"bifunctional" poly(2,6-dimethyl-l,4-phenylene ether) having an intrinsic viscosity of
0.12 deciliters per gram, Example 13 contained poly(2,6-dimethyl-l,4-phenylene
ether) having an intrinsic viscosity of 0.086 deciliters per gram, and Example 14
contained poly(2,6-dimethyl-l,4-phenylene ether) having an intrinsic viscosity of
0.064 deciliters per gram. The formulations were initially prepared in two parts. The
first part contained the following components: 229.50 grams FB570 spherical fused
silica from Denka, 25.50 grams of SFP30 spherical fused silica from Denka, 0.90
grams of MICHEM® Wax 411 from Michelman, and 0.60 grams of Cabot BLACK
PEARLS® 120. The poly(arylene ether)-containing compositions further contained
6.44 grams of the specified poly(arylene ether) in micronized form (i.e., passed
through a 400 mesh sieve).
21

WO 2007/005346 PCT/US2006/024666
In separate containers, the resin portions of the formulations were prepared by mixing
and melt blending 12.00 grams of RSS1407 LC Epoxy Resin (Yuka Shell), 48.00
grams of CNE195XL4 Epoxidized Cresol Novolac (Chang Chung), 0.60 grams of
UV9392c Diaryliodonium Salt (GE Silicones), and 0.30 grams of copper
acetylacetonate (Cu(acac)2-, Aldrich). This was done by combining the epoxy resins in
a beaker, heating them with stirring in a 150°C oil bath until they melted, then after
cooling to about 100°C, adding the OPPI (UV9392c) and copper acetylacetonate.
Once homogeneous, the molten resin blend was poured into the silica resin solid mix
described above. These mixtures were then processed 6 times through a 2-roll mill
with one roll set at 60°C and the other at 90°C. The complete formulations are given
in Table 7.
Table 7

Component Example 11 Examples 12-14
FB570 spherical fused silica from Denka 229.50 229.50
SFP30 spherical fused silica from Denka 25.50 25.50
MICHEM® Wax 411 from Michelman 0.90 0.90
Cabot BLACK PEARLS® 120 0.60 0.60
Poly(arylene ether) 0 6.44
RSS1407 LC Epoxy Resin (Yuka Shell) 12.00 10.22
CNE195XL4 Epoxidized Cresol Novolac (Chang 48.00 40.89
Chung)
OPPI 0.60 0.51
Copper Acetylacetonate (Aldrich) 0.30 0.26
22

WO 2007/005346 PCT/US2006/024666
The compounds were molded on a transfer press at 165°C. After demolding the
samples were then post-baked for two hours at 175°C before testing. Gel time, which
is a commonly used measure of cure speed, was measured as follows: a small portion
of curable composition was placed on a metal plate which had been heated to 165°C;
the time at which the composition gels was determined by probing with a spatula or
wooden tongue depressor. Other properties were measured as described above.
Property results are summarized in Table 8. The results show that Examples 12-14,
containing poly(arylene ether), exhibit substantially improved copper adhesion
strength compared to Example 11 with no poly(arylene ether). Adhesion strengths
were particularly and surprisingly improved for the Example 13 and 14 compositions
containing poly(arylene ether) having intrinsic viscosities in the range 0.05-0.10
deciliters/gram. The results also show that the poly(arylene ether)-containing samples
do not significantly inhibit curing in these compositions, where curing is catalyzed by
a combination of an iodonium salt and copper acetylacetonate. In contrast, samples
using a curing catalyst of iodonium salt plus benzopinacole showed substantial
inhibition of curing when poly(arylene ether) was added.
Table 8

Property Ex. 11 Ex. 12 Ex. 13 Ex. 14
Gel Time at 165°C (sec) 11 12 10 9
Spiral Flow at 165°C (cm) 90.2 50.8 47.8 45.7
Cu Pull Tab Adhesion (N) 35 69 197 170
Flexural Strength (MPa) 142 116 133 134
Moisture Absorbance (%) 0.214 0.222 0.247 0.226
23

WO 2007/005346 PCT/US2006/024666
EXAMPLES 15-21
Seven conventionally cured compositions (i.e., without latent cationic cure catalyst)
varying in type and amount of poly(arylene ether) were prepared and tested. The
poly(2,6-dimethyl-l,4-phenylene ether) resins having intrinsic viscosities of 0.12 and
0.30 deciliters/gram used in Examples 16 and 17 were obtained from GE Advanced
Materials. The poly(2,6-dimethyl-l,4-phenylene ether) resins having intrinsic
viscosities of 0.058, 0.078, and 0.092 deciliters/gram used in Examples 19-21 were
prepared by oxidative copolymerization of 2,6-xylenol and tetramethylbisphenol A
and as described, for example, in U.S. Patent No. 4,521,584 to Heitz et al. The epoxy
resin gamma-glycidoxypropyltrimethoxysilane was obtained as Z6040 from Dow.
The compositions were prepared by mixing the ingredients first in a Henschel mixer,
and then passing them through a twin-screw extruder set at 60°C in the rear section
and 90°C in the front section. After cooling and hardening, the materials were then
ground to a powder using a Retch mill. Sample compositions are detailed in Table 9,
with component amounts given in parts by weight.
24

WO 2007/005346 PCT/US2006/024666
Table 9

Component Ex.15 Ex.16 Ex.17
FB570 Silica (Denka) 1476.0 1476.0 1476.0
SFP30 Silica (Denka) 164.00 164.00 164.00
Z6040 Silane (Dow Coming) 10.93 10.93 10.93
RSS1407LC Epoxy Resin (Yuka Shell) 63.04 53.58 53.58
CNE 195XL-4 ECN (Chang Chung) 136.79 116.27 116.27
Tamanol 758 Phenol Novolac 97.45 82.83 82.83
(Arakawa)
Triphenyl Phosphine (Aldrich) 4.77 4.06 4.06
0.12 IV PPE (GE Advanced Materials) 0 50.86 0
0.30 IV PPE (GE Advanced Materials) 0 0 50.86
0.058 IV PPE 0 0 0
0.078 IV PPE 0 0 0
0.092 IV PPE 0 0 0
Camauba Wax (Michelman) 6.00 6.00 6.00
Black Pearls 120 (Cabot) 4.00 4.00 4.00
Antimony Oxide 16.04 16.04 16.04
Tetrabromo Bisphenol A (Great Lakes) 20.97 20.97 20.97
25

WO 2007/005346 PCT/US2006/024666
Table 9 (cont.)

Component Ex.18 Ex.19 Ex.20 Ex.21
FB570 Silica (Denka) 1107.0 1107.0 1107.0 1107.0
SFP30 Silica (Denka) 123.0 123.0 123.0 123.0
Z6040 Silane (Dow Corning) 8.20 8.20 8.20 8.20
RSS1407LC Epoxy Resin (Yuka Shell) 47.28 40.19 40.19 40.19
CNE 195XL-4 ECN (Chang Chung) 102.6 87.21 87.21 87.21
Tamanol 758 Phenol Novolac 73.09 62.12 62.12 62.12
(Arakawa)
Triphenyl Phosphine (Aldrich) 3.58 3.04 3.04 3.04
0.12 IV PPE (GE Advanced Materials) 0 0 0 0
0.30 IV PPE (GE Advanced Materials) 0 0 0 0
0.058 IV PPE 0 38.14 0 0
0.078 IV PPE 0 0 38.14 0
0.092 IV PPE 0 0 0 38.14
Carnauba Wax (Michelman) 4.50 4.50 4.50 4.50
Black Pearls 120 (Cabot) 3.00 3.00 3.00 3.00
Antimony Oxide 12.03 10.22 10.22 10.22
Tetrabromo Bisphenol A (Great Lakes) 15.73 13.37 13.37 13.37
26

WO 2007/005346 PCT/US2006/024666
The formulations were molded on a transfer press at 175°C. After demolding, the
parts were then post-baked at 175°C for 6 hours before testing. Property values,
measured as described above, are given in Table 10. The results show that in the
conventionally cured epoxy compositions, copper adhesion is nearly independent of
the type or amount of poly(arylene ether) present. This further illustrates that the high
adhesion strengths observed for cationically cured compositions 13 and 14 with low
intrinsic viscosity poly(arylene ether) resins are unexpected and surprising.
Table 10

Property Ex. 15 Ex. 16 Ex. 17 Ex. 18 Ex. 19 Ex.20 Ex.21
Gel Time at 175°C 25 26 24 23 24 22 26
(sec)
Spiral Flow at 175°C 129.5 68.6 71.1 129.5 114.3 99.1 99.1
(cm)
CTE1 (ppm/°C) 12 11 12 — —
CTE2 (ppm/°C) 44 39 44 — — —
Tg (°C) 139 146 144 — — — —
Cu Pull Tab Adhesion 85 96 88 76 84 88 92
(N)
Flex. Strength (MPa) 126 115 120 132 118 126 136
Moisture Absorbance 0.245 0.239 0.260 0.230 0.211 0.201 0.199
(%)
27

WO 2007/005346 PCT/US2006/024666
EXAMPLE 22

28
The example describes the preparation of an acid-difunctionalized poly(arylene ether).
A bifunctional poly(arylene ether) having an intrinsic viscosity of 0.12 deciliters/gram
at 25°C in chloroform was synthesized by the oxidative copolymerization of 2,6-
xylenol and 2,2-bis(4-hydroxy-2,6-dimethylphenyl)propane ("tetramethyl bisphenol
A" or "TMBPA") using a procedure similar to those described in U.S. Patent Nos.
4,665,137 to Percec (at column 5, lines 39-43) and 4,677,185 to Heitz et al. The
bifunctional poly(arylene ether) (50 grams) was dissolved in toluene (150 milliliters)
and reacted with succinic anhydride (6.4 grams) in the presence of 4-
dimethylaminopyridine ("DMAP"; 0.4 grams) for four hours at 95-100°C to yield an
acid-difunctionalized poly(arylene ether), as showing in Scheme 1, below. In Scheme
1, a and b have values such that the sum of a and b is sufficient to give the
bifunctional poly(arylene ether) an intrinsic viscosity of 0.12 deciliters per gram. The
solvent was then removed on a rotary evaporator and then excess succinic anhydride
and most of the DMAP were removed by washing with methanol. After drying, about
45.1 g of product was obtained. As a final purification (to make sure all the DMAP
was gone) the product was dissolved in 150 milliliters of toluene and then precipitated
into 1000 milliliters methanol containing 0.3 gram of toluene sulfonic acid. After
collection by suction filtration the product was washed two times with methanol and
then dried again in a vacuum oven. The final yield was 41.4 g.

WO 2007/005346 PCT/US2006/024666
EXAMPLE 23
The example describes the preparation and testing of a curable composition containing
the acid-difunctionalized poly(arylene ether) prepared in Example 22. The
formulation was initially prepared in two parts. The first part contained the following
components: 229.50 grams FB570 spherical fused silica from Denka, 25.50 grams of
SFP30 spherical fused silica from Denka, 0.90 grams of MICHEM® Wax 411 from
Michelman, 0.60 gram of carbon black obtained as Cabot BLACK PEARLS® 120s,
and 6.42 grams of micronized (passed through a 325 mesh sieve) acid-
difunctionalized poly(arylene ether) as prepared above.
In separate containers, the resin portions of the formulations were prepared by mixing
and melt blending 10.18 grams of RSS1407 LC Epoxy Resin (Yuka Shell), 40.72
grams of CNE195XL4 Epoxidized Cresol Novolac (Chang Chung), 0.51 gram of
OPPI (UV9392c Diaryliodonium Salt, GE Silicones), and 0.51 gram benzopinacole
(Aldrich). This was done by combining the epoxy resins in a beaker, heating them
with stirring in a 150°C oil bath until they melted, then after cooling to about 100°C,
and adding the UV9392c and benzopinacole. Once homogeneous, the molten resin
blend was poured into the silica resin solid mix described above. The resulting
mixture was then processed 6 times through a 2-roll mill with one roll set at 60°C and
the other at 90°C. The complete composition is provided in Table 11.
29

WO 2007/005346 PCT/US2006/024666
Table 11

Component Example 23
FB570 spherical fused silica from Denka 229.50
SFP30 spherical fused silica from Denka 25.50
MICHEM® Wax 411 from Michelman 0.90
Cabot BLACK PEARLS® 120s 0.60
acid-difunctionalized poly(arylene ether) 6.42
RSS1407 LC Epoxy Resin (Yuka Shell) 10.18
CNE195XL4 Epoxidized Cresol Novolac (Chang Chung) 40.72
OPPI 0.51
Benzopincole (Aldrich) 0.51
The compound was molded on a transfer press at 175°C. After demolding, the
samples were then post-baked for two hours at 175°C before testing. Property values
are provided in Table 12.
30

WO 2007/005346 PCT/US2006/024666
Table 12

Property Example 23
Gel Time at 175°C (sec) 12-13
Spiral Flow at 175°C (cm) 68.1
Cu Pull Tab Adhesion (N) 52
Flexural Strength (MPa) 129
Moisture Absorbance (%) 0.255
While the invention has been described with reference to a preferred embodiment, it
will be understood by those skilled in the art that various changes may be made and
equivalents may be substituted for elements thereof without departing from the scope
of the invention. In addition, many modifications may be made to adapt a particular
situation or material to the teachings of the invention without departing from the
essential scope thereof. Therefore, it is intended that the invention not be limited to
the particular embodiment disclosed as the best mode contemplated for carrying out
this invention, but that the invention will include all embodiments falling within the
scope of the appended claims.
All cited patents, patent applications, and other references are incorporated herein by
reference in their entirety.
All ranges disclosed herein are inclusive of the endpoints, and the endpoints are
combinable with each other.
The use of the terms "a" and "an" and "the" and similar referents in the context of
describing the invention (especially in the context of the following claims) are to be
construed to cover both the singular and the plural, unless otherwise indicated herein
or clearly contradicted by context.
31

WO 2007/005346 PCT/US2006/024666
CLAIMS:
1. A curable composition, comprising:
an epoxy resin;
a poly(arylene ether) resin;
an amount of a latent cationic cure catalyst effective to cure the epoxy resin; and
about 70 to about 95 weight percent of an inorganic filler, based on the total weight of
the curable composition.
2. The curable composition of claim 1, wherein the epoxy resin comprises an
epoxy resin having a softening point of about 25°C to about 150°C.
3. The curable composition of claim 1, wherein the epoxy resin is selected from
aliphatic epoxy resins, cycloaliphatic epoxy resins, bisphenol-A epoxy resins,
bisphenol-F epoxy resins, phenol novolac epoxy resins, cresol-novolac epoxy resins,
biphenyl epoxy resins, polyfunctional epoxy resins, naphthalene epoxy resins,
divinylbenzene dioxide, 2-glycidylphenylglycidyl ether, dicyclopentadiene-type epoxy
resins, multi aromatic resin type epoxy resins, and combinations thereof.
4. The curable composition of claim 1, wherein the epoxy resin comprises a
monomeric epoxy resin and an oligomeric epoxy resin.
5. The curable composition of claim 1, comprising about 70 to about 98 parts by
weight of the epoxy resin per 100 parts by weight total of the epoxy resin and the
poly(arylene ether) resin.
6. The curable composition of claim 1, wherein the poly(arylene ether) resin
comprises a plurality of repeating units having the structure
32

WO 2007/005346 PCT/US2006/024666

wherein each occurrence of Q2 is independently selected from hydrogen, halogen,
primary or secondary C1-C12 alkyl, C2-C12 alkenyl, C3-C12 alkenylalkyl, C2-C12
alkynyl, C3-C12 alkynylalkyl, C1-C12 hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-C12
hydrocarbyloxy, and C2-C12 halohydrocarbyloxy wherein at least two carbon atoms
separate the halogen and oxygen atoms; and wherein each occurrence of Q1 is
independently selected from halogen, primary or secondary C1-C12 alkyl, C2-C12
alkenyl, C3-C12 alkenylalkyl, C2-C12 alkynyl, C3-C12 alkynylalkyl, C1-C12
hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-C12 hydrocarbyloxy, and C2-C12
halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and
oxygen atoms.
7. The curable composition of claim 1, wherein the poly(arylene ether) has an
intrinsic viscosity of about 0.03 to about 1.0 deciliters per gram measured at 25°C in
chloroform.
8. The curable composition of claim 1, wherein the poly(arylene ether) resin has
an intrinsic viscosity of about 0.03 to 0.15 deciliters per gram measured at 25°C in
chloroform.
9. The curable composition of claim 1, wherein the poly(arylene ether) resin has
the structure
33

WO 2007/005346 PCT/US2006/024666

wherein each occurrence of Q2 is independently selected from hydrogen, halogen,
primary or secondary C1-C12 alkyl, C2-C12 alkenyl, C3-C12 alkenylalkyl, C2-C12
alkynyl, C3-C12 alkynylalkyl, C1-C12 hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-C12
hydrocarbyloxy, and C2-C12 halohydrocarbyloxy wherein at least two carbon atoms
separate the halogen and oxygen atoms; and wherein each occurrence of Q1 is
independently selected from hydrogen, halogen, primary or secondary C1-C12 alkyl,
C2-C12 alkenyl, C3-C12 alkenylalkyl, C2-C12 alkynyl, C3-C12 alkynylalkyl, C1-C12
hydroxyalkyl, phenyl, C1-C12 haloalkyl, C1-C12 hydrocarbyloxy, and C2-C12
halohydrocarbyloxy wherein at least two carbon atoms separate the halogen and
oxygen atoms; each occurrence of x is independently 1 to about 100; z is 0 or 1; and Y
has a structure selected from

wherein each occurrence of R and R is independently selected from hydrogen and
C1-C12 hydrocarbyl.
10. The curable composition of claim 1, wherein the poly(arylene ether) resin
comprises at least one terminal functional group selected from carboxylic acid,
glycidyl ether, vinyl ether, and anhydride.
11. The curable composition of claim 1, wherein the poly(arylene ether) resin is
substantially free of particles having an equivalent spherical diameter greater than 100
micrometers.
34

WO 2007/005346 PCT/US2006/024666
12. The curable composition of claim 1, comprising about 2 to about 30 parts by
weight of the poly(arylene ether) resin per 100 parts by weight total of the epoxy resin
and the poly(arylene ether) resin.
13. The curable composition of claim 1, wherein the latent cationic cure catalyst is
selected from diaryliodonium salts, phosphonic acid esters, sulfonic acid esters,
carboxylic acid esters, phosphonic ylides, benzylsulfonium salts, benzylpyridinium
salts, benzylammonium salts, isoxazolium salts, and combinations thereof.
14. The curable composition of claim 1, wherein the latent cationic cure catalyst
comprises a diaryliodonium salt having the structure
[(R3)(R4)I]+ X-
wherein R3 and R4 are each independently a C6-C14 monovalent aromatic hydrocarbon
radical, optionally substituted with from 1 to 4 monovalent radicals selected from
C1-C20 alkyl, C1-C20 alkoxy, nitro, and chloro; and wherein X- is an anion.
15. The curable composition of claim 1, wherein the latent cationic cure catalyst
comprises a diaryliodonium salt having the structure
[(R3)(R4)I]+ SbF6-
wherein R3 and R4 are each independently a C6-C14 monovalent aromatic hydrocarbon
radical, optionally substituted with from 1 to 4 monovalent radicals selected from C1-
C20 alkyl, C1-C20 alkoxy, nitro, and chloro.
16. The curable composition of claim 1, wherein the latent cationic cure catalyst
comprises 4-octyloxyphenyl phenyl iodonium hexafluoroantimonate.
17. The curable composition of claim 1, comprising about 0.1 to about 10 parts by
weight of the latent cationic cure catalyst per 100 parts by weight of the epoxy resin.
18. The curable composition of claim 1, wherein the inorganic filler is selected
from metal oxides, metal nitrides, metal carbonates, metal hydroxides, and
combinations thereof.
35

WO 2007/005346 PCT/US2006/024666
19. The curable composition of claim 1, wherein the inorganic filler is selected
from alumina, silica, boron nitride, aluminum nitride, silicon nitride, magnesia,
magnesium silicate, and combinations thereof.
20. The curable composition of claim 1, wherein the inorganic filler comprises a
fused silica.
21. The curable composition of claim 1, wherein the inorganic filler comprises,
based on the total weight of inorganic filler, about 75 to about 98 weight percent of a
first fused silica having an average particle size of 1 micrometer to about 30
micrometers, and about 2 to about 25 weight percent of a second fused silica having
an average particle size of about 0.03 micrometer to less than 1 micrometer.
22. The curable composition of claim 1, further comprising an effective amount of
a curing co-catalyst selected from free-radical generating aromatic compounds, peroxy
compounds, copper (II) salts of aliphatic carboxylic acids, copper (II) salts of aromatic
carboxylic acids, copper (II) acetylacetonate, and combinations thereof.
23. The curable composition of claim 22, wherein the curing co-catalyst comprises
benzopinacole.
24. The curable composition of claim 22, wherein the curing co-catalyst comprises
copper (II) acetylacetonate.
25. The curable composition of claim 1, further comprising a rubbery modifier
selected from polybutadienes, hydrogenated polybutadienes, polyisoprenes,
hydrogenated polyisoprenes, butadiene-styrene copolymers, hydrogenated butadiene-
styrene copolymers, butadiene-acrylonitrile copolymers, hydrogenated butadiene-
acrylonitrile copolymers, polydimethylsiloxanes, poly(dimethysiloxane-co-
diphenylsiloxane)s, and combinations thereof; wherein the rubbery modifier
comprises at least one functional group selected from hydroxy, hydrocarbyloxy, vinyl
ether, carboxylic acid, anhydride, and glycidyl.
26. The curable composition of claim 1, further comprising an additive selected
from phenolic hardeners, anhydride hardeners, silane coupling agents, flame
36

WO 2007/005346 PCT/US2006/024666
retardants, mold release agents, pigments, thermal stabilizers, adhesion promoters, and
combinations thereof.
27. The curable composition of claim 1, wherein the composition is substantially
free of polystyrene,
28. A curable composition, comprising:
about 70 to about 98 parts by weight of an epoxy resin comprising a monorneric epoxy
resin and an oligomeric epoxy resin;
about 2 to about 30 parts by weight of a poly(2,6-dimethyl-l,4-phenylene ether) resin
having an intrinsic viscosity of about 0.05 to about 0.10 deciliters per gram at 25°C in
chloroform;
an amount of a diaryliodonium salt effective to cure the epoxy resin; wherein the
diaryliodonium salt has the structure
[(R10)(R11)I]+SbF6-
wherein R10 and R11 are each independently a C6-C14 monovalent aromatic
hydrocarbon radical, optionally substituted with from 1 to 4 monovalent radicals
selected from C1-C20alkyl, C1-C20 alkoxy, nitro, and chloro; and
about 70 to about 95 weight percent silica filler, wherein the silica filler comprises
about 75 to about 98 weight percent of a first fused silica having an average particle
size of 1 micrometer to about 30 micrometers, and about 2 to about 25 weight percent
of a second fused silica having an average particle size of about 0.03 micrometer to
less than 1 micrometer;
wherein the parts by weight of the epoxy resin and the poly(arylene ether) are based
on 100 parts by weight total of the epoxy resin and the poly(arylene ether); and
wherein the weight percent of the silica filler is based on the total weight of the
curable composition.
37

WO 2007/005346 PCT/US2006/024666
29. A method of preparing a curable composition, comprising
blending
an epoxy resin,
a poly(arylene ether) resin,
an amount of a latent cationic cure catalyst effective to cure the epoxy resin, and
about 70 to about 95 weight percent of an inorganic filler, based on the total weight of
the curable composition,
to form an intimate blend.
30. A method of preparing a curable composition, comprising:
dry blending an epoxy resin, a poly(arylene ether) resin, an amount of a latent cationic
cure catalyst effective to cure the epoxy resin, and about 70 to about 95 weight percent
of an inorganic filler, based on the total weight of the curable composition, to form a
first blend;
melt mixing the first blend at a temperature of about 90 to about 115°C to form a
second blend;
cooling the second blend; and
grinding the cooled second blend to form the curable composition.
31. A method of encapsulating a solid state device, comprising:
encapsulating a solid state device with a curable composition comprising
an epoxy resin;
a poly(arylene ether) resin;
an amount of a latent cationic cure catalyst effective to cure the epoxy resin; and
38

WO 2007/005346 PCT/US2006/024666
about 70 to about 95 weight percent of an inorganic filler, based on the total weight of
the curable composition; and
curing the curable composition.
32. An encapsulated solid state device, comprising:
a solid state device; and
a cured composition encapsulating the solid state device, wherein the cured
composition comprises the products obtained on curing a curable composition
comprising
an epoxy resin;
a poly(arylene ether) resin;
an amount of a latent cationic cure catalyst effective to cure the epoxy resin; and
39
about 70 to about 95 weight percent of an inorganic filler, based on the total weight of
the curable composition.

A curable resin composition useful for encapsulating solid state devices is describe The
composition includes an epoxy resin, a poly(arylene ether) resin, a latent cationic cure
catalyst effective to cure the epoxy resin, and about 70 to about 95 weight perce of an
inorganic filler, based on the total weight of the curable composition. A method of
encapsulating a solid state device with the composition and encapsulated device
prepared with the composition are also described.

Documents

Application Documents

# Name Date
1 02610-kolnp-2007-abstract.pdf 2011-10-07
1 2610-KOLNP-2007-INTERNATIONAL SEARCH AUTHORITY REPORT 1.1.pdf 2011-10-07
2 02610-kolnp-2007-claims.pdf 2011-10-07
2 2610-KOLNP-2007-INTERNATIONAL PRELIMINARY REPORT.pdf 2011-10-07
3 2610-KOLNP-2007-CORRESPONDENCE OTHERS 1.2.pdf 2011-10-07
3 02610-kolnp-2007-correspondence others-1.1.pdf 2011-10-07
4 02610-kolnp-2007-priority document.pdf 2011-10-07
4 02610-kolnp-2007-correspondence others.pdf 2011-10-07
5 02610-kolnp-2007-pct request form.pdf 2011-10-07
5 02610-kolnp-2007-description complete.pdf 2011-10-07
6 02610-kolnp-2007-others.pdf 2011-10-07
6 02610-kolnp-2007-drawings.pdf 2011-10-07
7 02610-kolnp-2007-international search report.pdf 2011-10-07
7 02610-kolnp-2007-form 1.pdf 2011-10-07
8 02610-kolnp-2007-international publication.pdf 2011-10-07
8 02610-kolnp-2007-form 2.pdf 2011-10-07
9 02610-kolnp-2007-form 3.pdf 2011-10-07
9 02610-kolnp-2007-gpa.pdf 2011-10-07
10 02610-kolnp-2007-form 5.pdf 2011-10-07
11 02610-kolnp-2007-form 3.pdf 2011-10-07
11 02610-kolnp-2007-gpa.pdf 2011-10-07
12 02610-kolnp-2007-form 2.pdf 2011-10-07
12 02610-kolnp-2007-international publication.pdf 2011-10-07
13 02610-kolnp-2007-form 1.pdf 2011-10-07
13 02610-kolnp-2007-international search report.pdf 2011-10-07
14 02610-kolnp-2007-drawings.pdf 2011-10-07
14 02610-kolnp-2007-others.pdf 2011-10-07
15 02610-kolnp-2007-description complete.pdf 2011-10-07
15 02610-kolnp-2007-pct request form.pdf 2011-10-07
16 02610-kolnp-2007-correspondence others.pdf 2011-10-07
16 02610-kolnp-2007-priority document.pdf 2011-10-07
17 02610-kolnp-2007-correspondence others-1.1.pdf 2011-10-07
17 2610-KOLNP-2007-CORRESPONDENCE OTHERS 1.2.pdf 2011-10-07
18 02610-kolnp-2007-claims.pdf 2011-10-07
18 2610-KOLNP-2007-INTERNATIONAL PRELIMINARY REPORT.pdf 2011-10-07
19 2610-KOLNP-2007-INTERNATIONAL SEARCH AUTHORITY REPORT 1.1.pdf 2011-10-07
19 02610-kolnp-2007-abstract.pdf 2011-10-07